Drug Trial Radar · NCT07577856
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Last checked: Nov 19, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
644
Planned (sponsor's estimate)
Start
May 23, 2026
Primary completion
Aug 11, 2028
Study completion Oct 16, 2030
Sponsor
- Lead sponsor
- Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- May 11, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess how well JNJ-78934804 works (efficacy) and how safe it is (safety) as compared to guselkumab at Week 48 in participants with moderately to severely active ulcerative colitis (UC, a chronic disease of the large intestine in which the lining of the colon becomes inflamed and develops ulcers).
Conditions
- Colitis, Ulcerative
Interventions
JNJ-78934804Drug
JNJ-78934804 will be administered subcutaneously.
GuselkumabDrug
Guselkumab will be administered subcutaneously.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants in Clinical Remission at Week 48Time frame: At Week 48
Locations
318 sites in 33 countries. Site status is shown where the registry gives one.
Mayo Clinic
Scottsdale, Arizona · Recruiting
GIA Sun City
Sun City, Arizona · Recruiting
Clinnova Research
Anaheim, California · Recruiting
Gastro SB Clinic
Chula Vista, California · Recruiting
United Medical Doctors
Los Alamitos, California · Recruiting
Medical Associates Research Group, Inc.
San Diego, California · Recruiting
Peak Gastroenterology Associates
Colorado Springs, Colorado · Recruiting
Florida Research Center Inc.
Lakewood Rch, Florida · Recruiting
Sanchez Clinical Research, Inc
Miami, Florida · Recruiting
Endoscopic Research Inc
Orlando, Florida · Recruiting
GCP Clinical Research
Tampa, Florida · Recruiting
Atlanta Gastroenterology Specialists
Suwanee, Georgia · Recruiting
Tri-State Gastroenterology Assoc
Crestview Hills, Kentucky · Recruiting
Gastroenterology Clinic of Acadiana
Lafayette, Louisiana · Recruiting
GIA Metairie
Metairie, Louisiana · Recruiting
GIA Kansas City
Lee's Summit, Missouri · Recruiting
New York Gastroenterology Associates
New York, New York · Recruiting
University of North Carolina Hospital
Chapel Hill, North Carolina · Recruiting
Great Lakes Gastroenterology Research, LLC
Mentor, Ohio · Recruiting
Digestive Disease Specialists Inc
Oklahoma City, Oklahoma · Recruiting
The Oregon Clinic
Portland, Oregon · Recruiting
Michigan Center of Medical Research
Farmington Hill, Pennsylvania · Recruiting
Frontier Clinical Research
Uniontown, Pennsylvania · Recruiting
Palmetto Primary and Specialty Care Physicians, Charleston
Summerville, South Carolina · Recruiting
Gastro One
Cordova, Tennessee · Recruiting
Southern Star Research Institute, LLC
San Antonio, Texas · Recruiting
Tyler Research Institute, LLC
Tyler, Texas · Recruiting
GIA Webster
Webster, Texas · Recruiting
GIA Richmond
Richmond, Virginia · Recruiting
GI Alliance Tacoma
Tacoma, Washington · Recruiting
Instituto Medico De Alta Complejidad (IMAC)
Buenos Aires, Argentina · Recruiting
GEDYT
Famailla, Argentina · Recruiting
Globalpsy
La Plata, Argentina · Recruiting
HIGEA
Mendoza, Argentina · Recruiting
Instituto de Investigaciones Clinicas Quilmes
Quilmes, Argentina · Recruiting
Hospital Provincial del Centenario
Rosario, Argentina · Recruiting
MR Medicina Reumatologica
San Fernando, Argentina · Recruiting
Banksia Trials SA
Adelaide, Australia · Recruiting
Royal Prince Alfred Hospital
Camperdown, Australia · Recruiting
Monash Medical Centre
Clayton, Australia · Recruiting
Showing 40 of 318 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.